Scholar Rock Holding (SRRK) Shares Issued (2018 - 2026)
Scholar Rock Holding's quarterly Shares Issued came in at $98.0 million in Q1 2026, up 1852.19% year-on-year from $5.0 million in Q1 2025, and up 661.7% quarter-over-quarter from $12.9 million in Q4 2025.
Scholar Rock Holding has reported Shares Issued for 9 years, with the latest figure at $98.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Issued rose 1852.19% year-over-year to $98.0 million; the trailing twelve-month figure through Mar 2026 stood at $116.8 million (up 720.97% YoY), and the FY2025 full-year result was $23.8 million, up 147.39% from the prior year.
- Shares Issued for Q1 2026 stood at $98.0 million, up from $12.9 million in the prior quarter.
- The five-year high for Shares Issued was $195.3 million in Q2 2022, with the low at -$195.3 million in Q3 2022.
- Average Shares Issued over 5 years is $20.5 million, with a median of $2.2 million recorded in 2023.
- Peak annual rise in Shares Issued reached 31863.99% in 2022, while the deepest fall reached 10298.12% in 2022.
- Tracing SRRK's Shares Issued over 5 years: stood at $194.8 million in 2022, then slumped by 99.7% to $580000.0 in 2023, then soared by 506.72% to $3.5 million in 2024, then surged by 265.62% to $12.9 million in 2025, then soared by 661.7% to $98.0 million in 2026.
- The last three Shares Issued figures came in at $98.0 million (Q1 2026), $12.9 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 98.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.00 Mn |
| Mar 31, 2026 | 98.00 Mn |
| Dec 31, 2025 | 12.87 Mn |
| Dec 31, 2025 | 12.87 Mn |
| Sep 30, 2025 | 7.58 Mn |
| Sep 30, 2025 | 7.58 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Jun 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Mar 31, 2025 | 5.02 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Dec 31, 2024 | 3.52 Mn |
| Jun 30, 2024 | 5.69 Mn |
| Jun 30, 2024 | 5.69 Mn |
| Mar 31, 2024 | 419,000.00 |
| Mar 31, 2024 | 419,000.00 |
| Dec 31, 2023 | 580,000.00 |
| Dec 31, 2023 | 580,000.00 |
| Sep 30, 2023 | 280,000.00 |
| Sep 30, 2023 | 280,000.00 |
| Jun 30, 2023 | -288,000.00 |
| Jun 30, 2023 | -288,000.00 |
| Mar 31, 2023 | 827,000.00 |
| Mar 31, 2023 | 827,000.00 |
| Dec 31, 2022 | 194.83 Mn |
| Dec 31, 2022 | 194.83 Mn |
| Sep 30, 2022 | -195.29 Mn |
| Sep 30, 2022 | -195.29 Mn |
| Jun 30, 2022 | 195.30 Mn |
| Jun 30, 2022 | 195.30 Mn |
| Mar 31, 2022 | 481,000.00 |
| Mar 31, 2022 | 481,000.00 |
| Dec 31, 2021 | 7.83 Mn |
| Dec 31, 2021 | 7.83 Mn |
| Sep 30, 2021 | 1.92 Mn |
| Sep 30, 2021 | 1.92 Mn |
| Jun 30, 2021 | 611,000.00 |
| Jun 30, 2021 | 611,000.00 |
| Mar 31, 2021 | 2.74 Mn |
| Mar 31, 2021 | 2.74 Mn |
| Dec 31, 2020 | 5.92 Mn |
| Dec 31, 2020 | 5.92 Mn |
| Sep 30, 2020 | 374,000.00 |
| Sep 30, 2020 | 374,000.00 |
| Jun 30, 2020 | 598,000.00 |
| Jun 30, 2020 | 598,000.00 |
| Mar 31, 2020 | 405,000.00 |
| Mar 31, 2020 | 405,000.00 |
| Dec 31, 2019 | 48.21 Mn |
| Dec 31, 2019 | 48.21 Mn |
| Jun 30, 2019 | 42.00 Mn |
| Jun 30, 2019 | 42.00 Mn |
| Mar 31, 2019 | 13,000.00 |
| Mar 31, 2019 | 13,000.00 |
| Dec 31, 2018 | 3,000.00 |
| Dec 31, 2018 | 3,000.00 |
| Jun 30, 2018 | 77.80 Mn |
| Jun 30, 2018 | 77.80 Mn |